#1 Clinical Trials Search in Europe

DESMOPRESSIN

Desmopressin (also known as DDAVP) is a synthetic analog of the natural hormone vasopressin that has been studied extensively in various clinical settings. This medication works primarily by increasing water reabsorption in the kidneys and promoting the release of clotting factors from blood vessel walls. Clinical trials have investigated desmopressin across diverse conditions including nocturnal enuresis (bedwetting), nocturia (excessive nighttime urination), bleeding disorders, Parkinson’s disease, and more. This article summarizes the current research on desmopressin’s applications, effectiveness, and safety considerations based on recent clinical trials.

Table of Contents

What is Desmopressin?

Desmopressin (also known as DDAVP) is a synthetic version of vasopressin, a natural hormone produced by the pituitary gland. It was developed as a medication to help the body manage fluid balance and prevent excessive urination. Desmopressin is a selective agonist (activator) of the vasopressin type 2 receptor, which affects water reabsorption in the kidneys [1].

Common brand names for desmopressin include Minirin, Minirin Melt, Nocturin, and DDAVP. It has been used medically for decades and is on the World Health Organization’s List of Essential Medicines [2].

How Desmopressin Works

Desmopressin functions primarily by mimicking the action of antidiuretic hormone (ADH) released by the posterior pituitary gland. When it binds to vasopressin type 2 receptors in the kidneys, it triggers increased water reabsorption in the collecting tubules. This reduces urine production and makes the urine more concentrated [1].

Additionally, desmopressin stimulates the release of von Willebrand factor (VWF) and Factor VIII from endothelial cells into the bloodstream. These are important clotting factors that help prevent or control bleeding. This makes desmopressin useful for treating certain bleeding disorders [3].

Medical Conditions Treated with Desmopressin

Nocturnal Enuresis (Bedwetting)

Desmopressin is widely used to treat nocturnal enuresis (bedwetting) in children and adults. By reducing urine production at night, it helps prevent bedwetting episodes. Clinical trials have shown that desmopressin can significantly reduce the number of wet nights in patients with this condition [2].

For monosymptomatic nocturnal enuresis (bedwetting without other bladder symptoms), desmopressin is considered a first-line treatment alongside behavioral strategies. It’s particularly effective in children with reduced nighttime urinary concentration capacity [1].

Nocturia and Nocturnal Polyuria

Nocturia (frequent nighttime urination) caused by nocturnal polyuria (excessive urine production at night) can significantly affect sleep quality and overall well-being. Desmopressin helps reduce nighttime urination frequency by decreasing urine production.

Clinical trials have demonstrated that desmopressin significantly reduces the number of nighttime voids and increases the initial period of undisturbed sleep in patients with nocturia [4].

Diabetes Insipidus

Central diabetes insipidus is a condition characterized by insufficient production of vasopressin, leading to excessive thirst and urination. Desmopressin effectively treats this condition by replacing the missing hormone [5].

Bleeding Disorders

Desmopressin is used to treat or prevent bleeding in patients with mild to moderate hemophilia A, von Willebrand disease, and certain platelet function disorders. It works by increasing the levels of clotting factors in the blood.

Clinical trials have shown that intravenous desmopressin can increase Factor VIII levels significantly in patients with mild hemophilia A and in carriers of the hemophilia A gene [3]. It’s also being studied for use in platelet dysfunction associated with mild hypothermia and in patients taking aspirin or other medications that affect platelet function [6].

Other Medical Conditions

Research is ongoing into other potential uses for desmopressin, including:

  • Reducing postoperative bleeding in cardiac and other surgeries [7]
  • Managing bleeding in colorectal cancer patients [8]
  • Controlling bedwetting in patients with sickle cell disease [9]
  • Treating nocturnal enuresis in patients after bladder reconstruction surgery [10]
  • Managing nocturnal micturition frequency in patients with Parkinson’s disease [11]

Available Formulations

Desmopressin is available in several different formulations:

  • Oral tablets: Traditional tablets that are swallowed with water
  • Oral lyophilisate (MELT): A tablet that dissolves quickly when placed under the tongue, without the need for water. This formulation has better bioavailability (0.5%) compared to traditional tablets (0.2%) [12]
  • Nasal spray: Applied directly into the nasal cavity (has higher bioavailability at about 2%, but carries an increased risk of hyponatremia) [12]
  • Injectable solution: For intravenous or subcutaneous administration, usually in hospital settings

The choice of formulation depends on the condition being treated, patient preference, and the specific needs of the patient. For example, the MELT formulation may be more suitable for children who have difficulty swallowing tablets [13].

Dosage Information

Dosages of desmopressin vary depending on the condition being treated, the patient’s age, weight, and the specific formulation being used:

  • For nocturnal enuresis in children: Typically 120-240 μg of oral lyophilisate or 0.2-0.4 mg of tablet formulation taken at bedtime [14]
  • For nocturia in adults: Usually 25-50 μg of oral lyophilisate or 0.1-0.4 mg of tablet formulation taken at bedtime [15]
  • For hemophilia A and von Willebrand disease: Typically 0.3 μg/kg administered intravenously or subcutaneously [3]
  • For diabetes insipidus: Dosing is individualized based on response, typically starting with lower doses and titrating upward as needed [5]

It’s important to follow your doctor’s prescription exactly. Taking more than the prescribed dose can lead to serious side effects, particularly water retention and hyponatremia (low sodium levels in the blood).

Potential Side Effects

Like all medications, desmopressin can cause side effects. Common side effects include:

  • Headache
  • Nausea
  • Mild abdominal pain
  • Facial flushing
  • Nasal congestion (with nasal spray formulation)

The most serious potential side effect is hyponatremia (low sodium levels in the blood), which can occur if there’s excessive water retention. Symptoms of hyponatremia include:

  • Headache
  • Nausea and vomiting
  • Confusion
  • Seizures
  • In severe cases, coma

The risk of hyponatremia is higher in elderly patients and those who drink large amounts of fluid while taking desmopressin. Clinical trials have monitored sodium levels closely, particularly during the first week of treatment [4].

Other less common side effects reported in clinical trials include:

  • Increased blood pressure
  • Dizziness
  • Diarrhea
  • Dry mouth (xerostomia)
  • Dry eyes (xerophthalmia)
  • Blurred vision
  • Difficulty swallowing
  • Constipation
  • Rhinitis

Precautions and Contraindications

Desmopressin should be used with caution in certain situations and is contraindicated (should not be used) in others:

Contraindications:

  • Hyponatremia (low sodium levels)
  • Habitual or psychogenic polydipsia (excessive drinking)
  • Severe renal impairment (creatinine clearance below 50 ml/min)
  • Congestive heart failure
  • Known hypersensitivity to desmopressin

Use with caution in patients with:

  • Conditions associated with fluid and electrolyte imbalance
  • Moderate renal impairment
  • Cardiovascular disease
  • Hypertension
  • Cystic fibrosis
  • Advanced age (elderly patients are at increased risk of hyponatremia)

Fluid intake should be limited to a minimum from 1 hour before until 8 hours after taking desmopressin to reduce the risk of water intoxication and hyponatremia [16].

Use in Special Populations

Children

Desmopressin is widely used in children for the treatment of nocturnal enuresis. The oral lyophilisate (MELT) formulation is often preferred for children as it doesn’t require water for administration and has better bioavailability. Studies have shown that desmopressin is effective and generally well-tolerated in children when used at appropriate doses [13].

Elderly Patients

Elderly patients are at increased risk of developing hyponatremia with desmopressin treatment. Lower doses may be required, and sodium levels should be monitored carefully, especially at the start of treatment. Fluid restriction is particularly important in this population [16].

Patients with Sickle Cell Disease

Research is ongoing into the use of desmopressin for treating nocturnal enuresis in patients with sickle cell disease. Preliminary studies suggest it may be effective, but more research is needed to fully establish its safety and efficacy in this population [9].

Pregnant Women

There are limited data on the use of desmopressin during pregnancy. It should only be used if the potential benefit justifies the potential risk to the fetus. Always consult with your healthcare provider if you are pregnant or planning to become pregnant.

Current Research and Future Applications

Ongoing research is exploring new applications for desmopressin:

  • Cancer Treatment: Studies are investigating the potential role of desmopressin in cancer treatment, particularly for breast and colorectal cancers. Preliminary research suggests it might help reduce the formation of metastases by affecting the survival of circulating tumor cells [17].
  • Surgical Applications: Research is examining the use of desmopressin to reduce bleeding in various surgical procedures, including cardiac valve surgery, rhinoplasty, and surgeries in patients with acquired von Willebrand disease [18].
  • Personalized Medicine: Studies are looking at genetic factors that influence response to desmopressin, particularly in hemophilia A patients and carriers. This could lead to more personalized treatment approaches in the future [19].

As research continues, our understanding of desmopressin’s effects and potential applications continues to grow. This may lead to improved treatment protocols and new therapeutic uses in the future.

Condition Desmopressin Formulations Typical Dosages Key Findings from Clinical Trials
Nocturnal Enuresis (Bedwetting) Oral tablets, Oral lyophilisate (melt) 60-240 μg per day Significantly reduces wet nights in children; oral melt shows better absorption than tablets; effectiveness varies based on underlying cause
Nocturia/Nocturnal Polyuria Oral tablets, Oral lyophilisate (melt) 25-120 μg at bedtime Reduces nighttime voids; improves first undisturbed sleep period; risk of hyponatremia requires monitoring, especially in elderly
Hemophilia A (Mild/Moderate) Intravenous injection 0.3 μg/kg Increases Factor VIII levels; response varies based on F8 gene mutations; useful alternative to factor concentrates in some patients
Parkinson’s Disease with Nocturia Oral tablets 0.2 mg once or twice daily May reduce nocturnal urination frequency in Parkinson’s patients, addressing an often overlooked symptom
Bleeding Associated with Hypothermia Subcutaneous injection 1.5-15 μg May improve hypothermia-induced platelet dysfunction; even low doses (1.5 μg) show efficacy
Central Diabetes Insipidus Oral lyophilisate (melt), Intranasal 60-180 μg per day Effectively reduces urine volume and increases urine concentration; oral melt formulation provides an alternative to intranasal
Surgical Bleeding Management Intravenous injection 0.3-0.4 μg/kg May reduce bleeding in specific surgical contexts; particularly useful for patients with acquired von Willebrand disease or platelet dysfunction
Sickle Cell Disease with Bedwetting Oral tablets 0.2-0.4 mg at bedtime May reduce bedwetting in sickle cell patients, who have higher rates of nocturnal enuresis than the general population
Cancer (Investigational) Intravenous injection Varying doses under investigation Preliminary studies exploring potential anti-tumor effects; mechanism may involve anti-metastatic properties

FAQ

  • What conditions is desmopressin used to treat? Desmopressin is used to treat several conditions, including nocturnal enuresis (bedwetting) in children and adults, nocturia (excessive nighttime urination), central diabetes insipidus (a condition causing excessive urination), hemophilia A (mild to moderate), von Willebrand disease, and certain bleeding disorders. Clinical trials have also explored its use in Parkinson's disease patients with nighttime urination issues, patients with hypothermia-induced bleeding problems, and as a potential treatment for certain types of cancer.
  • How does desmopressin work in the body? Desmopressin works primarily as a selective agonist of the vasopressin type 2 receptor (V2R). This action causes several effects: 1) It increases water reabsorption in the kidneys' collecting tubules, reducing urine production, 2) It stimulates the release of von Willebrand factor and Factor VIII from blood vessel walls, which helps improve blood clotting, 3) In the treatment of bedwetting, it reduces nighttime urine production, leading to decreased bladder filling during sleep. These mechanisms make it effective for treating conditions involving excess urination or bleeding problems.
  • What are the different formulations of desmopressin available? Desmopressin is available in several formulations: 1) Oral tablets (e.g., Desmotabs, Minirin, Nocturin), 2) Oral lyophilisate/melt formulation that dissolves under the tongue (e.g., Minirin Melt), 3) Intravenous solution for injection, 4) Subcutaneous injection, and 5) Nasal spray (though this formulation is less commonly recommended now due to safety concerns related to unpredictable absorption). Each formulation has different bioavailability and dosing requirements, with the oral melt formulation showing improved absorption compared to regular tablets.
  • What are the common side effects of desmopressin? Common side effects of desmopressin include hyponatremia (low sodium levels in the blood), which is the most serious concern, especially in elderly patients. Other side effects may include headache, nausea, mild abdominal pain, and water retention. Less common side effects observed in clinical trials included nasal congestion, rhinitis (with nasal formulations), flushing, and changes in blood pressure. The risk of hyponatremia can be minimized by restricting fluid intake around the time of desmopressin administration and monitoring sodium levels, particularly at the start of treatment.
  • How effective is desmopressin for treating bedwetting in children? Clinical trials show desmopressin is effective for treating bedwetting (nocturnal enuresis) in children, with many patients experiencing a significant reduction in wet nights. In studies, desmopressin reduced the frequency of bedwetting by 50% or more in many children with monosymptomatic nocturnal enuresis. The oral lyophilisate (melt) formulation has shown particularly good results in children. However, response varies between individuals, and some children may benefit more than others. Factors affecting response include the underlying cause of bedwetting, with children who have reduced nighttime urinary concentrating ability typically responding better to treatment.

Ongoing Clinical Trials on DESMOPRESSIN

  • Study Comparing Desmopressin and Desmopressin Acetate in Children with Bedwetting (Nocturnal Enuresis)

    Not yet recruiting

    1 1 1 1
    Investigated drugs:
    Denmark

Glossary

  • Nocturnal Enuresis: The involuntary passage of urine during sleep past the age of expected bladder control (typically 5-7 years). This is commonly known as bedwetting.
  • Nocturia: The condition of waking one or more times during the night to urinate. It's often caused by excessive urine production during sleep (nocturnal polyuria).
  • Nocturnal Polyuria: A condition where the body produces an abnormally large volume of urine during sleep. It's defined as nighttime urine production exceeding 35% of the total 24-hour urine volume.
  • Hemophilia A: A genetic bleeding disorder caused by a deficiency in clotting factor VIII, resulting in impaired blood clotting and increased bleeding tendencies.
  • Desmopressin: A synthetic analog of vasopressin (antidiuretic hormone) that reduces urine production by increasing water reabsorption in the kidneys and also increases levels of certain clotting factors in the bloodstream.
  • DDAVP: The common abbreviation for desmopressin acetate, the synthetic version of vasopressin used in medical treatments.
  • Minirin Melt: A brand name for desmopressin in oral lyophilisate (freeze-dried) formulation that dissolves quickly when placed under the tongue.
  • Hyponatremia: A condition characterized by abnormally low levels of sodium in the blood, which can occur as a side effect of desmopressin due to increased water retention.
  • Factor VIII: A blood clotting protein that's deficient in people with hemophilia A. Desmopressin can temporarily increase Factor VIII levels in some patients.
  • Von Willebrand Factor (VWF): A blood protein that helps platelets stick to damaged blood vessels to form clots. Desmopressin increases VWF release from blood vessel walls.
  • Central Diabetes Insipidus: A condition caused by insufficient production of vasopressin, resulting in excessive urination and thirst. It's different from diabetes mellitus (related to blood sugar).
  • Oral Lyophilisate: A freeze-dried formulation of medication that dissolves quickly when placed on or under the tongue, allowing for rapid absorption.
  • Monosymptomatic Nocturnal Enuresis: Bedwetting that occurs without any other lower urinary tract symptoms or history of bladder dysfunction.
  • Pharmacokinetics: The study of how a drug is absorbed, distributed, metabolized, and eliminated by the body over time.
  • Pharmacodynamics: The study of the biochemical and physiological effects of drugs on the body, including the relationship between drug concentration and effect.
  • Antidiuretic Effect: The reduction in urine production caused by increased water reabsorption in the kidneys, which is one of the main effects of desmopressin.
  • Platelet Dysfunction: An impairment in the ability of platelets to form blood clots, which can occur in various conditions and may be improved by desmopressin in some cases.
  • Acquired von Willebrand Disease: A bleeding disorder similar to von Willebrand disease but not inherited; it can develop as a complication of other medical conditions, such as aortic stenosis.

References

  1. https://clinicaltrials.gov/study/NCT06285006
  2. https://clinicaltrials.gov/study/NCT02538302
  3. https://clinicaltrials.gov/study/NCT02506023
  4. https://clinicaltrials.gov/study/NCT01439997
  5. https://clinicaltrials.gov/study/NCT01280188
  6. https://clinicaltrials.gov/study/NCT00902057
  7. https://clinicaltrials.gov/study/NCT03343418
  8. https://clinicaltrials.gov/study/NCT01623206
  9. https://clinicaltrials.gov/study/NCT04420585
  10. https://clinicaltrials.gov/study/NCT01582542
  11. https://clinicaltrials.gov/study/NCT00806468
  12. https://clinicaltrials.gov/study/NCT01036841
  13. https://clinicaltrials.gov/study/NCT02584231
  14. https://clinicaltrials.gov/study/NCT01078753
  15. https://clinicaltrials.gov/study/NCT03089073
  16. https://clinicaltrials.gov/study/NCT04329975
  17. https://clinicaltrials.gov/study/NCT01606072
  18. https://clinicaltrials.gov/study/NCT01994330
  19. https://clinicaltrials.gov/study/NCT05628558